West Pharmaceutical Services raised its annual profit forecast on Thursday, anticipating a boost from a weaker dollar to ...

The Swiss pharma giant made one of the most significant financial promises to bolster its domestic manufacturing capabilities as the Trump administration weighs levying tariffs on drugmakers.

Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they ...

The stock's fall snapped a three-day winning streak.

Bristol-Myers Squibb Company's Q1 2025 earnings reveal revenue decline but EPS growth. Click to discover BMY challenges, ...

With potential tariffs and other drug pricing policies on the horizon, the industry is navigating uncertain waters. | The ...

After weeks of threats, Trump announced on April 2 a series of broad tariffs on goods imported to the United States from most ...

Roche has said it is petitioning the Trump administration for an exemption from threatened tariffs for pharmaceuticals, ...

Shares of Inovio Pharmaceuticals Inc. INO advanced 2.67% to $1.92 Thursday, on what proved to be an all-around great trading ...

Unfortunately, the same cannot be said for Europe. While it has been home to some of the most important biopharmaceutical companies in the world – many of which have consistently delivered ...

Not since Franklin Roosevelt has a new president driven so many shifts, so fast. Here's 100 things that have already changed ...

Alnylam (ALNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.